Integrating abortion into Canada’s primary health care system with mifepristone
Bibliographic record
Abstract
Although the majority of abortions worldwide are performed surgically, termination of pregnancy using medication (termed "medication abortion" in reproductive health fields) 1 is becoming more common due to its costeffectiveness, accessibility, and desirability among patients.Mifepristone, also known as RU486, is an anti-progesterone steroid, and it is considered the gold standard of medication abortion.2 This medication is taken in the form of a tablet and is effective for early abortion up through 63 days (nine weeks) after the start of the last menstrual period.When mifepristone is used in conjunction with misoprostol, a medication that induces uterine contractions, the regimen results in a complete abortion 95-98% of the time. 2 Despite this regimen being the international gold standard, mifepristone is currently not registered in Canada and is therefore unavailable for commercial distribution in the country.However, early 2014 was met with national media reports and discussions within the published literature about a pending Health Canada application to register the drug.3 In the midst of awaiting a decision from Health Canada, it is important to consider the potential role for mifepristone in Canada's healthcare system.Mifepristone could increase access to abortion at the primary health care level due to the fact that it can be prescribed and administered by a variety of providers.4 Therefore, mifepristone's registration in Canada should be of tremendous interest to primary health care practitioners and patients.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.013 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.003 | 0.003 |
| Science and technology studies | 0.007 | 0.002 |
| Scholarly communication | 0.005 | 0.001 |
| Open science | 0.002 | 0.003 |
| Research integrity | 0.002 | 0.003 |
| Insufficient payload (model declined to judge) | 0.014 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".